FENC analyst estimates

Fennec Pharmaceuticals (FENC) analyst ratings, the average price target and its range, and every firm's latest call.

FENC analyst ratings and price targets

DateFirmCallTarget
Aug 12, 2026WedbushFennec price target raised to $16 from $13 at Wedbush$16.00
May 22, 2026H.C. WainwrightFennec price target raised to $16 from $13 at H.C. Wainwright$16.00
Jan 8, 2026Piper SandlerFennec initiated with an Overweight at Piper Sandler$18.00
Aug 15, 2025Craig-HallumFennec price target raised to $14 from $13 at Craig-Hallum$14.00
May 15, 2024H.C. WainwrightFennec Pharmaceuticals Inc. (FENC) PT Lowered to $15 at H.C. Wainwright$15.00
May 15, 2024Craig-HallumFennec price target lowered to $17 from $20 at Craig-Hallum$17.00
Apr 4, 2024H.C. WainwrightFennec price target raised to $18 from $17 at H.C. Wainwright$18.00
Mar 19, 2024Craig-HallumFennec Pharmaceuticals Inc. (FENC) PT Raised to $18 at Craig-Hallum$18.00
Nov 22, 2022Cantor FitzgeraldCantor Fitzgerald Upgrades Fennec Pharmaceuticals to Overweight, Raises Price Target to $12$12.00
Sep 26, 2022WedbushWedbush Maintains Outperform on Fennec Pharmaceuticals, Raises Price Target to $19$19.00

Updated 2026-11-17 17:46 UTC